Morgan Stanley
MGRX icon

Morgan Stanley’s Mangoceuticals MGRX Stock Holding History

Morgan Stanley’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380 Hold
1,000
– – ﹤0.01% 7741
2026
Q1 		$360 Hold
1,000
– – ﹤0.01% 7650
2025
Q4 		$740 Buy
+1,000
New +$1.62K ﹤0.01% 7431
2024
Q3 		– Sell
-691
Closed -$3.15K – 7993
2024
Q2 		$3.15K Hold
691
– – ﹤0.01% 6969
2024
Q1 		$2.25K Buy
+691
New +$2.75K ﹤0.01% 7047

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.47B AUM 24.93% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
AG
AmeriFlex Group Las Vegas, Nevada $245M AUM 37.62% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Morgan Stanley's MGRX Position: Q2 2026 in Review

Morgan Stanley held its Mangoceuticals (MGRX) position steady in Q2 2026 at 1,000 shares worth $380. The position accounts for ﹤0.01% of the portfolio, ranked #7741.

Morgan Stanley first reported a position in MGRX in Q1 2024 and has held it in 5 quarters since. The position peaked at $3.15K in Q2 2024. 12 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • Morgan Stanley held 1,000 shares of Mangoceuticals worth $380 as of Q2 2026.
  • Morgan Stanley left its Mangoceuticals share count unchanged in Q2 2026.
  • Mangoceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7741 holding.
  • Morgan Stanley first reported a position in Mangoceuticals in Q1 2024 and has held it in 5 quarters since.
  • Morgan Stanley's Mangoceuticals position peaked at $3.15K in Q2 2024.
  • 12 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.